RecruitingNCT03142022

Sleep-disordered Breathing After Solid Organ Transplantation


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

300 participants

Start Date

Nov 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients 1 year after lung transplantation

Exclusion Criteria2

  • Refusal of PSG
  • Medical contra-indication to perform PSG

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention - Diagnostic polysomnography at 1 year after lung transplantation

Locations(1)

UZ Leuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03142022


Related Trials